e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Respiratory disorders in paediatric intensive care unit
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alpha1-antitrypsin (α1-AT) and secretory leukocyte protease inhibitor (SLPI) in acute lung injury/acute respiratory distress syndrome (ALI/ARDS) in critically ill infants
S. El-Sahrigy, M. Abdel-Aziz, A. Hamed (Cairo, Egypt)
Source:
Annual Congress 2008 - Respiratory disorders in paediatric intensive care unit
Session:
Respiratory disorders in paediatric intensive care unit
Session type:
E-Communication Session
Number:
473
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. El-Sahrigy, M. Abdel-Aziz, A. Hamed (Cairo, Egypt). Alpha1-antitrypsin (α1-AT) and secretory leukocyte protease inhibitor (SLPI) in acute lung injury/acute respiratory distress syndrome (ALI/ARDS) in critically ill infants. Eur Respir J 2008; 32: Suppl. 52, 473
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: respiratory care for newborns in resource-limited settings
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Proteinomics and ARDS
Source: Annual Congress 2007 - Acute respiratory distress syndrome: from basic science to bedside
Year: 2007
Corticosteroids and acute respiratory distress syndrome (ARDS)
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007
TGF-β inhibits alveolar fluid reabsorption: a role in ARDS?
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007
Acute respiratory distress in infants and young children [respiratory distress syndrome (RDS), acute RDS (ARDS), and bronchiolotis]
Source: International Congress 2014 – Noninvasive respiratory support for infants and young children
Year: 2014
KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome
Source: Eur Respir J 2004; 23: 142-145
Year: 2004
Surfactant therapy in acute lung injury/acute respiratory distress syndrome
Source: Eur Respir Mon 2012; 55: 54-64
Year: 2012
Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006
Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006
An animal model of the acute respiratory distress syndrome (ARDS)
Source: Eur Respir J 2002; 20: Suppl. 38, 486s
Year: 2002
What has been learnt from P/V curves in patients with acute lung injury/acute respiratory distress syndrome
Source: Eur Respir J 2003; 22: 22S-26S
Year: 2003
Usefulness of a selective neutrophil elastase inhibitor and a recombinant human soluble thrombomodulin in patients with ARDS and DIC
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013
Exogenous pulmonary surfactant combined with recruitment maneuver in prevention of alveolar derecruitment in rabbits with acute respiratory distress syndrome
Source: Annual Congress 2007 - Lung recruitment
Year: 2007
Clinico-pathological analysis of acute respiratory distress syndrome (ARDS)
Source: Annual Congress 2012 - Multidisciplinary critical care
Year: 2012
Surfactant metabolism and replacement in acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=119
Year: 2002
COVID-19 patient with acute respiratory distress syndrome (ARDS) benefit most from an early prone position
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021
Role of heat shock proteins in the lungs of acute lung injury
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006
Impaired ventilation is not independently associated with 28-day mortality in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS)
Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome
Year: 2021
Recruitment manoeuvres in acute lung injury/acute respiratory distress syndrome
Source: Eur Respir J 2003; 22: 37S-42S
Year: 2003
Mechanisms of acute lung injury
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
Eosinophilic pneumonia (acute, chronic)
Source: Respipedia Article
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept